We are live on ! Find out more
LP

LMR Partners Portfolio holdings

AUM $45.4B
1-Year Est. Return 60.68%
This Fund
S&P 500
This Quarter Est. Return
+17.46%
1 Year Est. Return
+60.68%
3 Year Est. Return
+183.94%
5 Year Est. Return
+215.13%
10 Year Est. Return
+663.15%
AUM
$14B
AUM Growth
+$3.28B
Cap. Flow
+$324M
Cap. Flow %
2.32%
Top 10 Hldgs %
24.44%
Holding
1,743
New
418
Increased
280
Reduced
331
Closed
391

Top Buys

Rank Stock Value
1
MUB icon
iShares National Muni Bond ETF
MUB
+$176M
2
INFY icon
Infosys
INFY
+$102M
3
K
Kellanova
K
+$74.6M
4
AMZN icon
Amazon
AMZN
+$58.6M
5
BABA icon
Alibaba
BABA
+$52.5M

Sector Composition

Rank Sector Weight
1 Technology 10.38%
2 Financials 4.13%
3 Consumer Discretionary 2.33%
4 Communication Services 2.26%
5 Healthcare 2.07%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
APTV icon
1326
CALL
Aptiv
APTV
$12B
-20,500
Closed -$1.22M
APTV icon
1327
PUT
Aptiv
APTV
$12B
-14,100
Closed -$839K
ARGT icon
1328
Global X MSCI Argentina ETF
ARGT
$842M
-20,000
Closed -$1.62M
ARVN icon
1329
CALL
Arvinas
ARVN
$518M
-21,100
Closed -$148K
ARVN icon
1330
Arvinas
ARVN
$518M
-68,700
Closed -$482K
ARVN icon
1331
PUT
Arvinas
ARVN
$518M
-101,600
Closed -$713K
ATAT icon
1332
Atour Lifestyle Holdings
ATAT
$4.35B
-35,000
Closed -$992K
AVXL icon
1333
CALL
Anavex Life Sciences
AVXL
$222M
-20,000
Closed -$172K
AVXL icon
1334
PUT
Anavex Life Sciences
AVXL
$222M
-25,000
Closed -$215K
AVY icon
1335
Avery Dennison
AVY
$12.3B
-1,137
Closed -$202K
AXON
1336
Axon Enterprise
AXON
$40.5B
-3,100
Closed -$1.63M
AZO icon
1337
AutoZone
AZO
$48.3B
-3,230
Closed -$12.3M
BBIO icon
1338
BridgeBio Pharma
BBIO
$16.5B
-4,492
Closed -$163K
BBWI icon
1339
Bath & Body Works
BBWI
$4.01B
-6,998
Closed -$212K
BDX icon
1340
Becton Dickinson
BDX
$43.1B
-1,720
Closed -$394K
BFLY icon
1341
Butterfly Network
BFLY
$1.72B
-108,247
Closed -$247K
BHF icon
1342
Brighthouse Financial
BHF
$3.63B
-80,000
Closed -$4.64M
BHF icon
1343
PUT
Brighthouse Financial
BHF
$3.63B
-100,000
Closed -$5.8M
BIIB icon
1344
Biogen
BIIB
$29.9B
-15,802
Closed -$2.16M
BKNG icon
1345
Booking.com
BKNG
$138B
-2,725
Closed -$558K
BMRN icon
1346
PUT
BioMarin Pharmaceuticals
BMRN
$11.5B
-9,800
Closed -$693K
BMY icon
1347
CALL
Bristol-Myers Squibb
BMY
$127B
-50,000
Closed -$3.05M
BRBR icon
1348
BellRing Brands
BRBR
$1.51B
-145,000
Closed -$10.8M
BRBS icon
1349
Blue Ridge Bankshares
BRBS
$311M
-32,838
Closed -$107K
BROS icon
1350
CALL
Dutch Bros
BROS
$8.78B
-29,300
Closed -$1.81M

Similar funds

LMR Partners's Q2 2025 Portfolio in Review

As of Q2 2025, LMR Partners held 1,743 positions worth $14B, up 31% from $10.7B the previous quarter. Its ten largest holdings account for 24% of the portfolio.

LMR Partners's Q2 2025 filing shows 418 new, 280 increased, 331 reduced and 391 closed positions. Its largest new stake was Infosys: 5,733,005 shares worth $106M. The largest sale was Intra-Cellular Therapies Inc., an estimated $114M.

By sector, the portfolio is most concentrated in Technology at 10% of assets, down from 11% a quarter earlier, followed by Financials and Consumer Discretionary.

  • LMR Partners's largest Q2 2025 buy was Infosys: 5,733,005 shares worth $106M.
  • LMR Partners added most to iShares National Muni Bond ETF in Q2 2025, an estimated $176M increase.
  • LMR Partners's biggest Q2 2025 reduction was Roper Technologies, cutting an estimated $45.7M.
  • LMR Partners fully exited Intra-Cellular Therapies Inc. in Q2 2025, selling an estimated $114M.
  • LMR Partners's ten largest holdings make up 24% of its $14B portfolio in Q2 2025.
  • LMR Partners opened 418 new positions and closed 391 in Q2 2025.
  • LMR Partners's portfolio value rose 31% quarter-over-quarter to $14B.

Based on LMR Partners's 13F filing for Q2 2025, filed 14 Aug 2025.